메뉴 건너뛰기




Volumn 54, Issue 9, 2015, Pages 1749-1751

On-demand treatment with anakinra: A treatment option for selected TRAPS patients

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SERUM AMYLOID A;

EID: 84983108468     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kev111     Document Type: Letter
Times cited : (42)

References (6)
  • 1
    • 84924275962 scopus 로고    scopus 로고
    • The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry
    • Lachmann HJ, Papa R, Gerhold K, et al. The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry. Ann Rheum Dis 2014;73:2160-7.
    • (2014) Ann Rheum Dis , vol.73 , pp. 2160-2167
    • Lachmann, H.J.1    Papa, R.2    Gerhold, K.3
  • 2
    • 84875963811 scopus 로고    scopus 로고
    • Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review
    • Ter Haar N, Lachmann H, Özen S, et al. Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review. Ann Rheum Dis 2013;72:678-85.
    • (2013) Ann Rheum Dis , vol.72 , pp. 678-685
    • Ter Haar, N.1    Lachmann, H.2    Özen, S.3
  • 3
    • 0037295409 scopus 로고    scopus 로고
    • Prospective study of anti-tumour necrosis factor receptor superfamily 1B fusion protein, and case study of anti-tumour necrosis factor receptor superfamily 1A fusion protein, in tumour necrosis factor receptor associated periodic syndrome (TRAPS): clinical and laboratory findings in a series of seven patients
    • Drewe E, McDermott EM, Powell PT, Isaacs JD, Powell RJ. Prospective study of anti-tumour necrosis factor receptor superfamily 1B fusion protein, and case study of anti-tumour necrosis factor receptor superfamily 1A fusion protein, in tumour necrosis factor receptor associated periodic syndrome (TRAPS): clinical and laboratory findings in a series of seven patients. Rheumatol Oxf 2003;42:235-9.
    • (2003) Rheumatol Oxf , vol.42 , pp. 235-239
    • Drewe, E.1    McDermott, E.M.2    Powell, P.T.3    Isaacs, J.D.4    Powell, R.J.5
  • 4
    • 43949128071 scopus 로고    scopus 로고
    • Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome
    • Gattorno M, Pelagatti MA, Meini A, et al. Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum 2008;58:1516-20.
    • (2008) Arthritis Rheum , vol.58 , pp. 1516-1520
    • Gattorno, M.1    Pelagatti, M.A.2    Meini, A.3
  • 5
    • 84883678117 scopus 로고    scopus 로고
    • Validation of the Auto-Inflammatory Diseases Activity Index (AIDAI) for hereditary recurrent fever syndromes
    • Piram M, Koné-Paut I, Lachmann HJ, et al. Validation of the Auto-Inflammatory Diseases Activity Index (AIDAI) for hereditary recurrent fever syndromes. Ann Rheum Dis 2014;73:2168-73.
    • (2014) Ann Rheum Dis , vol.73 , pp. 2168-2173
    • Piram, M.1    Koné-Paut, I.2    Lachmann, H.J.3
  • 6
    • 84860389029 scopus 로고    scopus 로고
    • On-demand anakinra treatment is effective in mevalonate kinase deficiency
    • Bodar EJ, Kuijk LM, Drenth JPH, et al. On-demand anakinra treatment is effective in mevalonate kinase deficiency. Ann Rheum Dis 2011;70:2155-8.
    • (2011) Ann Rheum Dis , vol.70 , pp. 2155-2158
    • Bodar, E.J.1    Kuijk, L.M.2    Drenth, J.P.H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.